Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the whitehall study

Journal of Clinical Epidemiology

Volumn 41, Issue 3, 1988, Pages 251-260

  Ebi Kryston, Kristie L ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Bronchitis; Cardiovascular diseases; Dyspnea; Lung volume measurements; Mortality; Respiratory tract diseases

Indexed keywords

ADULT; AGE; AGED; BRONCHITIS; CARDIOVASCULAR DISEASE; DYSPNEA; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY;

ADULT; CARDIOVASCULAR DISEASES; FORCED EXPIRATORY VOLUME; HUMAN; LONDON; LUNG; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGE; SMOKING; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023836635     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(88)90129-1     Document Type: Article

References (40)

1. Effects of pulmonary function on mortality
2. Physiological variables and mortality in patients with various categories of chronic respiratory disease
3. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia-l3-year study
4. Predictors of survival in subjects with chronic airflow limitation
5. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation
6. Impaired pulmonary function as a risk factor for mortality
7. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study
8. Coronary risk factors. Recent highlights from the Framingham study
9. Follow-up evaluation of a prevalence study for chronic bronchitis and chronic airways obstruction
10. Pulmonary function: relation to aging, cigarette habit, and mortality. The Framingham study
11. Predictors of mortality in the adult population of Tecumseh. Respiratory symptoms, chronic respiratory disease, and ventilatory lung function
12. The Veterans Administration Cooperative Study of pulmonary function. III. Mortality in relation to respiratory function in chronic obstructive pulmonary disease
13. Risks of Dying From Tuberculosis and Cardiorespiratory Disease in the West of Scotland
14. four cardiorespiratory symptoms as predictors of mortality
15. Chronic bronchitis-measurements and observations over 10 years
16. The predictive value of a postal questionnaire on cardio-respiratory symptoms
17. Definition and classification of chronic bronchitis for clinical and epidemiological purposes
18. Terminology definitions and classifications of chronic pulmonary emphysema and related conditions
19. The natural history of chronic airflow obstruction
20. Chronic obstructive lung disease a comparison between clinical roentgenologic functional and mor phologic criteria in chronic bronchitis emphysema asthma and bronchiectasis
21. Cardiorespiratory disease and diabetes among middle-aged male civil servants. A study of screening and intervention
22. Self-administration of a questionnaire on chest pain and intermittent claudication
23. Standardized questionnaires on respiratory symptoms
24. Regression models and life tables
25. Partial likelihood
26. Prevalence of chest symptoms in nonexposed blue-collar workers
27. Factors related to respiratory and cardiovascular symptoms in the United Kingdom
28. Smoking and health: the association between smoking behavior, total mortality, and cardiorespiratory disease in west central Scotland
29. Chronic respiratory disease in mining communities
30. The prevalence of chronic bronchitis, chronic airway obstruction and respiratory symptoms in a Colorado city
31. Employment grade and coronary heart disease in British civil servants
32. The effect of reduced pulmonary function on mortality; preliminary results from the NHANES I Epidemiologic Followup Study
33. The objective measurement of breathlessness
34. The measurement of dyspnea: Contents, interobserver agreement, and physiologic correlates of two new clinical indexes
35. Further specification and evaluation of a new clinical index for dyspnea